Airsculpt Technologies, Inc.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AIRSCULPT TECHNOLOGIES, INC.
Date: March 14, 2025
By: /s/ Yogi Jashnani
Yogi Jashnani
Chief Executive Officer
(Principal Executive Officer)
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Yogi Jashnani and Dennis Dean, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this report, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| SIGNATURES | TITLE | DATE |
|---|---|---|
| /s/ Yogi Jashnani | Chief Executive Officer, Director(Principal Executive Officer) | March 14, 2025 |
| Yogi Jashnani | ||
| /s/ Dennis Dean | Chief Financial Officer (Principal Financial Officer) | March 14, 2025 |
| Dennis Dean | ||
| /s/ Philip Bodie | Chief Accounting Officer(Principal Accounting Officer) | March 14, 2025 |
| Philip Bodie | ||
| /s/ Dr. Aaron Rollins | Executive Chairman of the Board | March 14, 2025 |
| Dr. Aaron Rollins | ||
| /s/ Adam Feinstein | Director | March 14, 2025 |
| Adam Feinstein | ||
| /s/ Daniel Sollof | Director | March 14, 2025 |
| Daniel Sollof | ||
| /s/ Caroline Chu | Director | March 14, 2025 |
| Caroline Chu | ||
| /s/ Thomas Aaron | Director | March 14, 2025 |
| Thomas Aaron | ||
| /s/ Kenneth Higgins | Director | March 14, 2025 |
| Kenneth Higgins | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.